看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 230.2x - 254.4x | 242.3x |
| Selected Fwd EBIT Multiple | 44.9x - 49.7x | 47.3x |
| Fair Value | ₺14.12 - ₺14.95 | ₺14.54 |
| Upside | -32.2% - -28.3% | -30.3% |
| Benchmarks | Ticker | Full Ticker |
| Aydem Yenilenebilir Enerji A.S. | AYDEM | IBSE:AYDEM |
| Aksa Enerji Üretim A.S. | AKSEN | IBSE:AKSEN |
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | CONSE | IBSE:CONSE |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | BIOEN | IBSE:BIOEN |
| Kartal Yenilenebilir Enerji Uretim A.S. | KARYE | IBSE:KARYE |
| Aksu Enerji ve Ticaret Anonim Sirketi | AKSUE | IBSE:AKSUE |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| AYDEM | AKSEN | CONSE | BIOEN | KARYE | AKSUE | ||
| IBSE:AYDEM | IBSE:AKSEN | IBSE:CONSE | IBSE:BIOEN | IBSE:KARYE | IBSE:AKSUE | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 8.4% | 40.7% | NM- | NM- | 49.7% | -20.8% | |
| 3Y CAGR | 31.8% | 41.4% | -17.4% | NM- | 84.0% | -36.7% | |
| Latest Twelve Months | -66.3% | -43.2% | 116.8% | -715.2% | 218.6% | -87.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 43.1% | 15.2% | -3.3% | 10.7% | 41.3% | 41.2% | |
| Prior Fiscal Year | 32.4% | 18.5% | -20.0% | 1.9% | 18.3% | 23.5% | |
| Latest Fiscal Year | 15.3% | 16.9% | 4.2% | -13.7% | 39.3% | 3.5% | |
| Latest Twelve Months | 15.3% | 16.9% | 4.2% | -13.7% | 39.3% | 3.5% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.27x | 2.25x | 2.98x | 4.98x | 5.49x | 16.23x | |
| EV / LTM EBITDA | 8.8x | 9.7x | 12.4x | 53.1x | 8.1x | 74.5x | |
| EV / LTM EBIT | 34.6x | 13.3x | 71.3x | -36.4x | 14.0x | 467.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -36.4x | 14.0x | 71.3x | ||||
| Historical EV / LTM EBIT | 29.6x | 74.0x | 467.7x | ||||
| Selected EV / LTM EBIT | 230.2x | 242.3x | 254.4x | ||||
| (x) LTM EBIT | 2 | 2 | 2 | ||||
| (=) Implied Enterprise Value | 499 | 525 | 551 | ||||
| (-) Non-shareholder Claims * | 418 | 418 | 418 | ||||
| (=) Equity Value | 916 | 942 | 969 | ||||
| (/) Shares Outstanding | 66.0 | 66.0 | 66.0 | ||||
| Implied Value Range | 13.88 | 14.28 | 14.68 | ||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 13.88 | 14.28 | 14.68 | 20.84 | |||
| Upside / (Downside) | -33.4% | -31.5% | -29.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | AYDEM | AKSEN | CONSE | BIOEN | KARYE | AKSUE | |
| Enterprise Value | 34,712 | 71,999 | 4,080 | 13,375 | 2,127 | 958 | |
| (+) Cash & Short Term Investments | 2,603 | 1,057 | 27 | 99 | 55 | 31 | |
| (+) Investments & Other | 0 | 6 | 0 | 319 | 0 | 431 | |
| (-) Debt | (24,371) | (28,167) | (1,979) | (3,953) | (546) | (44) | |
| (-) Other Liabilities | 0 | (3,886) | 0 | (10) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 12,944 | 41,009 | 2,128 | 9,830 | 1,636 | 1,375 | |
| (/) Shares Outstanding | 698.9 | 1,226.3 | 771.0 | 500.0 | 55.0 | 66.0 | |
| Implied Stock Price | 18.52 | 33.44 | 2.76 | 19.66 | 29.74 | 20.84 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 18.52 | 33.44 | 2.76 | 19.66 | 29.74 | 20.84 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |